my account log out | |
transferrin-Sap immunotoxin |
Create: 03/30/2017 |
Expired Date: | 03/08/2019 |
Category: | Drugs&Pharmaceutical [Health&Medical&Pharmaceutical] |
Message: | This immunotoxin was achieved by conjugating/fusing the transferrin to saporin. It was expressed in CHO and purified with affinity chromatography. The immunotoxin selectively binds to TFRC expressing cells and enters cells by receptor-mediated endocytosis. Upon release of the conjugate from endosomes, the saporin toxin catalytically renders the large subunit ribosomes unable to bind the elongation factors and inhibits protein synthesis. It was designed for treatment of T cell leukemias or lymphomas, graft-versus-host diseases, and autoimmune diseases. |
City: | Shirley[US] |
Location: | |
Feb 01 2023 | VBS++ (with Ca and Mg) Buffer | 214 | |
Feb 01 2023 | GVBE Buffer | 214 | |
Feb 01 2023 | GVB++ (with Ca and Mg) Buffer | 221 | |
Feb 01 2023 | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | 208 | |
Aug 30 2019 | Anti-HSV-2 gH Antibody | 392 | |
Aug 30 2019 | Anti-L. major LPG Antibody | 476 | |
Aug 30 2019 | Anti-DENV-1 Antibody | 385 | |
Aug 30 2019 | Anti-BPV-1 L1 Antibody | 401 | |
Aug 30 2019 | Anti-H3N2 HA Antibody | 387 | |
Aug 30 2019 | Anti-EIAV env Antibody | 411 |
Copyright © toextrade Inc. All rights reserved. Contact us |